Dr. Portale is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-2423Fax+1 415-476-9976
Education & Training
University of California (San Francisco)Residency, Pediatrics, 1977 - 1978
University at BuffaloResidency, Pediatrics, 1974 - 1977- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1974
Certifications & Licensure
CA State Medical License 1977 - 2026
FL State Medical License 2015 - 2017- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
Publications & Presentations
PubMed
- 184 citationsBurosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trialErik A. Imel, Francis H. Glorieux, Michael P. Whyte, Craig F Munns, Leanne Ward
Lancet. 2019-06-15 - 27 citationsEffect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia.Leanne M Ward, Francis H Glorieux, Michael P Whyte, Craig F Munns, Anthony A Portale
The Journal of Clinical Endocrinology and Metabolism. 2022-07-14 - 188 citationsA Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: W...Karl L. Insogna, Karine Briot, Erik A. Imel, Peter Kamenický, Mary D. Ruppe
Journal of Bone and Mineral Research. 2018-08-01
Journal Articles
- Vitamin D Insufficiency, Hemoglobin, and Anemia in Children with Chronic Kidney DiseaseAnthony A. Portale, Bradley A. Warady, Susan L. Furth, Juhi Kumar, Meredith A. Atkinson, Pediatric Nephrology
- A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti‐FGF23 Antibody, in Adults with X‐Linked Hypophosphatemia: W...Thomas Weber, Mary D Ruppe, Anthony A Portale, Erik A Imel, Thomas O Carpenter, Karl L Insogna, Farzana Perwad, Pisit Pitukcheewanont, Journal of Bone and Mineral Research
Press Mentions
Studies of A Gene for A Rare Form of Rickets Shed Light on Vitamin D DeficienciesMay 4th, 1999
Grant Support
- Disordered Mineral Metabolism In The Ckid Children: Role Of FGF-23National Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Phosphoproteomics Of FGF-23 Signaling Pathway In 1 Alpha-Hydroxylase RegulationNational Center For Research Resources2010–2011
- Bone Loss In Children With Complex Renal DiseaseNational Center For Research Resources2004–2005
- Molecular Regulation Of 1,25(Oh)2d ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2002
- Vitamin D Metabolism In Renal Tubular Acidosis And Fanconi SyndromeNational Center For Research Resources1985
- Vitamin D Metabolism In Post-Renal-Transplant StateNational Center For Research Resources1985
- Diurnal Variation In Blood And Urine Composition Of Minerals In HumanNational Center For Research Resources1985
- Determinants Of Vitamin D Synthesis And DegradationNational Center For Research Resources1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
